Yun Feng
No ORCID on file
· 7 papers in corpus
· active 2011-2021
Study types
- article 7
Condition tags
- adenomyosis 4
- endometriosis 3
- infertility 3
- dysmenorrhea 1
Top journals
Frequent coauthors
- Yijuan Sun 3
- Song Guo 2
- Zhihong Niu 2
- Chengbo Liu 1
- F. Yun 1
- Huimei Yao 1
- Di Zhang 1
- Jia Liu 1
- Jinfeng Xue 1
- Han Zhao 1
article
2021
BACKGROUND: Endometriosis is a common gynecological disease among women in their reproductive years. Although much effort has been made, the pathogenesis of this disease and the detailed differences between eutopic endometrial cells and ect…
article
2020
BACKGROUND: This cross-sectional study aimed to evaluate the levels of tumor necrosis factor-alpha (TNF-ɑ), interleukin-8 (IL-8), interleukin-6 (IL-6), and transforming growth factor-beta 1 (TGF-β1) in patients with primary and secondary tu…
article
2018
Purpose: Adenomyosis has a negative impact on female fertility. GnRH agonist treatment can improve pregnancy outcomes in women with adenomyosis. However, the impact of GnRH agonist upon endometrium receptivity of patients with adenomyosis r…
article
2017
PURPOSE: Adenomyosis is a common, benign gynecological condition of the female reproductive tract characterized by heavy menstrual bleeding and dysmenorrhea. Gonadotropin-releasing hormone (GnRH) agonists are one of the medications used in …
article
2015
article
2013
Some studies have shown that long-term gonadotropin-releasing hormone (GnRH) agonist administration before in vitro fertilization/intracytoplasmic sperm in infertile women with endometriosis or adenomyosis significantly increases the chance…
article
2011
GnRH agonist(GnRHa) is a kind of medicine most widely used to treat endometriosis.Endometriosis reduces the fecundity of women from many aspects.However,GnRHa can improve the abdominal and follicular environment,receptivity of uterine to em…